Normal lung development and function after Sox9 inactivation in the respiratory epithelium.

Area of Science:

• Developmental Biology
• Genetics
• Respiratory Medicine

Background:

• Heterozygous mutations in the human SOX9 gene are linked to campomelic dysplasia (CD), a severe skeletal malformation syndrome.
• CD patients often experience respiratory distress and mortality in the neonatal period, highlighting the importance of lung development and function.

Purpose of the Study:

• To investigate the dynamic expression pattern of Sox9 during mouse lung morphogenesis.
• To determine the specific role of Sox9 in lung development and postnatal function by inactivating it in respiratory epithelial cells.

Main Methods:

• Analyzed dynamic Sox9 expression in developing mouse lungs.
• Utilized a doxycycline-inducible Cre/loxP system for targeted Sox9 inactivation in respiratory epithelial cells.
• Performed immunohistochemical and RNA analysis to confirm gene inactivation and assess lung structure and function.

Main Results:

• Sox9 inactivation was confirmed in embryonic lung development by embryonic day 12.5.
• No significant alterations were observed in lung morphogenesis or postnatal lung function after Sox9 inactivation.
• No compensatory upregulation of other Sox family genes was detected.

Conclusions:

• Despite high expression during lung morphogenesis, Sox9 is not essential for normal lung structure, postnatal survival, or repair mechanisms in respiratory epithelial cells.
• These findings indicate a non-critical role for Sox9 in mouse lung development and function under the studied conditions.